nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT1A6—Estrogen metabolism—COMT—conduct disorder	0.0375	0.0375	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0342	0.0342	CbGpPWpGaD
Valproic Acid—ACADSB—Amino acid and derivative metabolism—CGA—conduct disorder	0.0332	0.0332	CbGpPWpGaD
Valproic Acid—OGDH—Amino acid and derivative metabolism—CGA—conduct disorder	0.0282	0.0282	CbGpPWpGaD
Valproic Acid—ABAT—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0259	0.0259	CbGpPWpGaD
Valproic Acid—UGT1A6—Oxidative Stress—MAOA—conduct disorder	0.0247	0.0247	CbGpPWpGaD
Valproic Acid—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0241	0.0241	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Valproic Acid—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Valproic Acid—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0166	0.0166	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—GABRA2—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0156	0.0156	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Valproic Acid—HDAC9—Initiation of transcription and translation elongation at the HIV-1 LTR—EP300—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Valproic Acid—UGT1A8—Phase II conjugation—COMT—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Valproic Acid—UGT2B15—Phase II conjugation—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—GABRA2—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Valproic Acid—HDAC9—NOTCH1 Intracellular Domain Regulates Transcription—EP300—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Valproic Acid—UGT1A6—Phase II conjugation—COMT—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00988	0.00988	CbGpPWpGaD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00981	0.00981	CbGpPWpGaD
Valproic Acid—UGT1A10—Metapathway biotransformation—COMT—conduct disorder	0.0098	0.0098	CbGpPWpGaD
Valproic Acid—CYP1A2—Methylation—COMT—conduct disorder	0.00975	0.00975	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00961	0.00961	CbGpPWpGaD
Valproic Acid—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—POLR3A—conduct disorder	0.00954	0.00954	CbGpPWpGaD
Valproic Acid—HDAC9—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—EP300—conduct disorder	0.00942	0.00942	CbGpPWpGaD
Valproic Acid—UGT1A6—NRF2 pathway—SLC6A4—conduct disorder	0.00927	0.00927	CbGpPWpGaD
Valproic Acid—UGT1A8—Biological oxidations—COMT—conduct disorder	0.00845	0.00845	CbGpPWpGaD
Valproic Acid—UGT1A8—Biological oxidations—MAOA—conduct disorder	0.00839	0.00839	CbGpPWpGaD
Valproic Acid—UGT1A4—Phase II conjugation—COMT—conduct disorder	0.00813	0.00813	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling events mediated by HDAC Class I—EP300—conduct disorder	0.00788	0.00788	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00783	0.00783	CbGpPWpGaD
Valproic Acid—HDAC9—FBXW7 Mutants and NOTCH1 in Cancer—EP300—conduct disorder	0.00779	0.00779	CbGpPWpGaD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00759	0.00759	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—COMT—conduct disorder	0.00757	0.00757	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—MAOA—conduct disorder	0.00752	0.00752	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—COMT—conduct disorder	0.00749	0.00749	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00744	0.00744	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—COMT—conduct disorder	0.00738	0.00738	CbGpPWpGaD
Valproic Acid—UGT2B15—Biological oxidations—MAOA—conduct disorder	0.00733	0.00733	CbGpPWpGaD
Valproic Acid—UGT1A4—NRF2 pathway—SLC6A4—conduct disorder	0.00716	0.00716	CbGpPWpGaD
Valproic Acid—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.00676	0.00676	CbGpPWpGaD
Valproic Acid—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00646	0.00646	CbGpPWpGaD
Valproic Acid—HDAC2—Transcription—POLR3A—conduct disorder	0.00646	0.00646	CbGpPWpGaD
Valproic Acid—HDAC2—Initiation of transcription and translation elongation at the HIV-1 LTR—EP300—conduct disorder	0.00639	0.00639	CbGpPWpGaD
Valproic Acid—UGT1A6—Biological oxidations—COMT—conduct disorder	0.00616	0.00616	CbGpPWpGaD
Valproic Acid—UGT1A6—Biological oxidations—MAOA—conduct disorder	0.00612	0.00612	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—CGA—conduct disorder	0.00609	0.00609	CbGpPWpGaD
Valproic Acid—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00609	0.00609	CbGpPWpGaD
Valproic Acid—UGT1A6—Metapathway biotransformation—COMT—conduct disorder	0.00608	0.00608	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.00595	0.00595	CbGpPWpGaD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00586	0.00586	CbGpPWpGaD
Valproic Acid—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.00575	0.00575	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—COMT—conduct disorder	0.00574	0.00574	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—MAOA—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—EP300—conduct disorder	0.00553	0.00553	CbGpPWpGaD
Valproic Acid—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0053	0.0053	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CGA—conduct disorder	0.00518	0.00518	CbGpPWpGaD
Valproic Acid—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.00506	0.00506	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00487	0.00487	CbGpPWpGaD
Valproic Acid—UGT1A4—Biological oxidations—COMT—conduct disorder	0.00476	0.00476	CbGpPWpGaD
Valproic Acid—UGT1A4—Biological oxidations—MAOA—conduct disorder	0.00473	0.00473	CbGpPWpGaD
Valproic Acid—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0047	0.0047	CbGpPWpGaD
Valproic Acid—HDAC2—NOTCH1 Intracellular Domain Regulates Transcription—EP300—conduct disorder	0.0047	0.0047	CbGpPWpGaD
Valproic Acid—UGT1A4—Metapathway biotransformation—COMT—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Valproic Acid—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.00467	0.00467	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00452	0.00452	CbGpPWpGaD
Valproic Acid—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.00441	0.00441	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—DRD4—conduct disorder	0.00425	0.00425	CbGpPWpGaD
Valproic Acid—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00415	0.00415	CbGpPWpGaD
Valproic Acid—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00413	0.00413	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Valproic Acid—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—EP300—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Valproic Acid—UGT1A3—Biological oxidations—COMT—conduct disorder	0.00396	0.00396	CbGpPWpGaD
Valproic Acid—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Valproic Acid—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.00393	0.00393	CbGpPWpGaD
Valproic Acid—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—EP300—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Valproic Acid—CYP2C18—Biological oxidations—COMT—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Valproic Acid—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.00343	0.00343	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling events mediated by HDAC Class I—EP300—conduct disorder	0.00342	0.00342	CbGpPWpGaD
Valproic Acid—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Valproic Acid—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—EP300—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00337	0.00337	CbGpPWpGaD
Valproic Acid—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Valproic Acid—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00334	0.00334	CbGpPWpGaD
Valproic Acid—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00332	0.00332	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CGA—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Valproic Acid—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Valproic Acid—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00311	0.00311	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00307	0.00307	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00304	0.00304	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00301	0.00301	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CGA—conduct disorder	0.00283	0.00283	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CGA—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00277	0.00277	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—COMT—conduct disorder	0.00275	0.00275	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—MAOA—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Valproic Acid—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Valproic Acid—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.0027	0.0027	CbGpPWpGaD
Valproic Acid—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—EP300—conduct disorder	0.00253	0.00253	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Valproic Acid—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—EP300—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—COMT—conduct disorder	0.00234	0.00234	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CGA—conduct disorder	0.00234	0.00234	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00233	0.00233	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—MAOA—conduct disorder	0.00232	0.00232	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—WASF1—conduct disorder	0.00227	0.00227	CbGpPWpGaD
Valproic Acid—PTGS1—Biological oxidations—COMT—conduct disorder	0.00223	0.00223	CbGpPWpGaD
Valproic Acid—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Valproic Acid—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.00201	0.00201	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EP300—conduct disorder	0.00196	0.00196	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CGA—conduct disorder	0.0018	0.0018	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—POLR3A—conduct disorder	0.0018	0.0018	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00171	0.00171	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—COMT—conduct disorder	0.0017	0.0017	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Valproic Acid—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Valproic Acid—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Valproic Acid—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—DRD4—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—EP300—conduct disorder	0.00147	0.00147	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—COMT—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Valproic Acid—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—MAOA—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Valproic Acid—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—EP300—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CGA—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00128	0.00128	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00128	0.00128	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CGA—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Valproic Acid—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—COMT—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—MAOA—conduct disorder	0.00125	0.00125	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CGA—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—EP300—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00116	0.00116	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00116	0.00116	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—COMT—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—MAOA—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR2A—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CGA—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—EP300—conduct disorder	0.001	0.001	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—COMT—conduct disorder	0.001	0.001	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000996	0.000996	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000994	0.000994	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000987	0.000987	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—WASF1—conduct disorder	0.000985	0.000985	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000851	0.000851	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CGA—conduct disorder	0.000844	0.000844	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—COMT—conduct disorder	0.000814	0.000814	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—MAOA—conduct disorder	0.000808	0.000808	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CGA—conduct disorder	0.000798	0.000798	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EP300—conduct disorder	0.000783	0.000783	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000772	0.000772	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—EP300—conduct disorder	0.000767	0.000767	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000767	0.000767	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000762	0.000762	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—COMT—conduct disorder	0.000725	0.000725	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—MAOA—conduct disorder	0.00072	0.00072	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—EP300—conduct disorder	0.000702	0.000702	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—DRD4—conduct disorder	0.000688	0.000688	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—COMT—conduct disorder	0.000676	0.000676	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MAOA—conduct disorder	0.000672	0.000672	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CGA—conduct disorder	0.000644	0.000644	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CGA—conduct disorder	0.000629	0.000629	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—EP300—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—COMT—conduct disorder	0.000591	0.000591	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MAOA—conduct disorder	0.000587	0.000587	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—COMT—conduct disorder	0.000575	0.000575	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MAOA—conduct disorder	0.000571	0.000571	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EP300—conduct disorder	0.000549	0.000549	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CGA—conduct disorder	0.000545	0.000545	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—EP300—conduct disorder	0.000542	0.000542	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CGA—conduct disorder	0.000487	0.000487	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—COMT—conduct disorder	0.000467	0.000467	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MAOA—conduct disorder	0.000464	0.000464	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—EP300—conduct disorder	0.000452	0.000452	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00045	0.00045	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR2A—conduct disorder	0.000449	0.000449	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CGA—conduct disorder	0.000444	0.000444	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—COMT—conduct disorder	0.000381	0.000381	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CGA—conduct disorder	0.000379	0.000379	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MAOA—conduct disorder	0.000378	0.000378	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000367	0.000367	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—COMT—conduct disorder	0.00036	0.00036	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MAOA—conduct disorder	0.000358	0.000358	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—EP300—conduct disorder	0.000349	0.000349	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EP300—conduct disorder	0.00034	0.00034	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—EP300—conduct disorder	0.000311	0.000311	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CGA—conduct disorder	0.000293	0.000293	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—COMT—conduct disorder	0.000291	0.000291	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—EP300—conduct disorder	0.00029	0.00029	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MAOA—conduct disorder	0.000289	0.000289	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—COMT—conduct disorder	0.000284	0.000284	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MAOA—conduct disorder	0.000282	0.000282	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—conduct disorder	0.000254	0.000254	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—conduct disorder	0.000247	0.000247	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—COMT—conduct disorder	0.000246	0.000246	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MAOA—conduct disorder	0.000244	0.000244	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—conduct disorder	0.000238	0.000238	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000237	0.000237	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—COMT—conduct disorder	0.00022	0.00022	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MAOA—conduct disorder	0.000218	0.000218	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000212	0.000212	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—conduct disorder	0.0002	0.0002	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—COMT—conduct disorder	0.0002	0.0002	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MAOA—conduct disorder	0.000199	0.000199	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000193	0.000193	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—COMT—conduct disorder	0.000171	0.000171	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MAOA—conduct disorder	0.00017	0.00017	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000165	0.000165	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—conduct disorder	0.000163	0.000163	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—conduct disorder	0.000155	0.000155	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—COMT—conduct disorder	0.000132	0.000132	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MAOA—conduct disorder	0.000131	0.000131	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—conduct disorder	0.000125	0.000125	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—conduct disorder	0.000122	0.000122	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—conduct disorder	0.000106	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—conduct disorder	9.42e-05	9.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—conduct disorder	8.59e-05	8.59e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—conduct disorder	7.34e-05	7.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—conduct disorder	5.67e-05	5.67e-05	CbGpPWpGaD
